Login / Signup

De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis.

Arif Ali AwanBrian HuttonJohn HiltonSasha MazzarelloCatherine Van PoznakLisa VandermeerBrianne BotaCarol StoberMarta SienkiewiczDean FergussonRisa ShorrMark Clemons
Published in: Breast cancer research and treatment (2019)
These data are supportive of de-escalation of zoledronate from onset for patients with bone metastases from breast cancer.
Keyphrases
  • open label
  • bone mineral density
  • electronic health record
  • big data
  • soft tissue
  • postmenopausal women
  • breast cancer risk
  • bone loss
  • body composition
  • artificial intelligence